Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Armoiry

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2017
Systematic Review and Network Meta-Analysis of Treatment Outcomes for Multiple MyelomaXavier Armoiry, Alexander Tsertsvadze, Martin Connock, et al.
Thrombosis Research|December 17, 2013
Self-testing of the International Normalized Ratio in adults with a mechanical heart valve: patient education and cost matterRoland Henaine, Philippe Chevalier, Anna-Maria Henaine, et al.
Journal of the American College of Cardiology|September 28, 2024
Plea for an In-Depth Analysis of the RESHAPE-HF2 ResultsJean-François Obadia, Xavier Armoiry, David Messika-Zeitoun, et al.
Clinical Neurology and Neurosurgery|February 7, 2018
The Woven EndoBridge (WEB) for endovascular therapy of intracranial aneurysms: Update of a systematic review with meta-analysisNoam Tau, Udi Sadeh-Gonik, Gilles Aulagner, et al.
Journal of Evidence-Based Medicine|May 24, 2024
Reconciling conflicting evidence in the evaluation of the MitraClip system: Assessment of and response to the MITRA-FR and COAPT trials by key stakeholdersManuela Montagnon, Yenfu Chen, Amy Grove, et al.
Journal of Market Access & Health Policy|September 7, 2019
Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myelomaXavier Armoiry, Hans-Martin Spath, Aileen Clarke, et al.
Critical Care (London, England)|August 8, 2020
Correction to: Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysisEnrique Guilherme, Matthias Jacquet-Lagrèze, Matteo Pozzi, et al.
Expert Opinion on Biological Therapy|December 28, 2020
Ocrelizumab not recommended in France for patients with primary progressive multiple sclerosis while recommended in England: a review comparing the assessment by HAS and NICEXavier Armoiry, Hans-Martin Späth, Anna-Maria Henaine, et al.
Critical Care (London, England)|July 18, 2020
Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysisEnrique Guilherme, Matthias Jacquet-Lagrèze, Matteo Pozzi, et al.
BMJ Open|March 14, 2023
Potential impact on cost-effectiveness estimates of using immature survival data: a case study based on transcatheter edge-to-edge repair (TEER) used for patients with severe mitral regurgitation at high surgical riskMartin Connock, Peter Auguste, Aude Capelle, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2017
Systematic Review and Network Meta-Analysis of Treatment Outcomes for Multiple MyelomaXavier Armoiry, Alexander Tsertsvadze, Martin Connock, et al.
Thrombosis Research|December 17, 2013
Self-testing of the International Normalized Ratio in adults with a mechanical heart valve: patient education and cost matterRoland Henaine, Philippe Chevalier, Anna-Maria Henaine, et al.
Journal of the American College of Cardiology|September 28, 2024
Plea for an In-Depth Analysis of the RESHAPE-HF2 ResultsJean-François Obadia, Xavier Armoiry, David Messika-Zeitoun, et al.
Clinical Neurology and Neurosurgery|February 7, 2018
The Woven EndoBridge (WEB) for endovascular therapy of intracranial aneurysms: Update of a systematic review with meta-analysisNoam Tau, Udi Sadeh-Gonik, Gilles Aulagner, et al.
Journal of Evidence-Based Medicine|May 24, 2024
Reconciling conflicting evidence in the evaluation of the MitraClip system: Assessment of and response to the MITRA-FR and COAPT trials by key stakeholdersManuela Montagnon, Yenfu Chen, Amy Grove, et al.
Journal of Market Access & Health Policy|September 7, 2019
Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myelomaXavier Armoiry, Hans-Martin Spath, Aileen Clarke, et al.
Critical Care (London, England)|August 8, 2020
Correction to: Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysisEnrique Guilherme, Matthias Jacquet-Lagrèze, Matteo Pozzi, et al.
Expert Opinion on Biological Therapy|December 28, 2020
Ocrelizumab not recommended in France for patients with primary progressive multiple sclerosis while recommended in England: a review comparing the assessment by HAS and NICEXavier Armoiry, Hans-Martin Späth, Anna-Maria Henaine, et al.
Critical Care (London, England)|July 18, 2020
Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysisEnrique Guilherme, Matthias Jacquet-Lagrèze, Matteo Pozzi, et al.
BMJ Open|March 14, 2023
Potential impact on cost-effectiveness estimates of using immature survival data: a case study based on transcatheter edge-to-edge repair (TEER) used for patients with severe mitral regurgitation at high surgical riskMartin Connock, Peter Auguste, Aude Capelle, et al.
Pageof 9